Increased risk of triple-negative breast cancer was observed for carriers of rare missense variants in PALB2 with an adjusted OR of 5.79 (1.32-25.29 95% CI, p-value = 0.020, Figure 3). The gene discussed is PALB2; the disease is triple-negative breast carcinoma.